Prognostic role of long non-coding RNA LINC00152 in Chinese cancer patients: a meta-analysis

Liyang Liu; Jianfei Wen; Xi Gu; Dongdong Wu; Ming Lu; Qinghong Zhao

doi:10.18632/oncotarget.21838

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Prognostic role of long non-coding RNA LINC00152 in Chinese cancer patients: a meta-analysis

Liyang Liu, Jianfei Wen, Xi Gu, Dongdong Wu, Ming Lu and Qinghong Zhao _

PDF | HTML | How to cite

Oncotarget. 2017; 8:93227-93235. https://doi.org/10.18632/oncotarget.21838

Metrics: PDF 1336 views | HTML 2432 views | ?

Abstract

Liyang Liu1,*, Jianfei Wen2,*, Xi Gu1,*, Dongdong Wu1, Ming Lu1 and Qinghong Zhao1

1Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

*These authors contributed equally to this work and Co-first authors

Correspondence to:

Qinghong Zhao, email: [email protected]

Keywords: LINC00152, cancer, metastasis, prognosis, meta-analysis

Received: July 20, 2017 Accepted: September 21, 2017 Published: October 12, 2017

ABSTRACT

The role of long intergenic non-coding RNA 152 (LINC00152) in predicting the prognosis of cancer has been investigated but results remain inconclusive and inconsistent. A meta-analysis was performed to explore the effect of LINC00152 on cancer prognosis. PubMed and ScienceDirect were searched for suitable studies and the results of 10 studies with a total of 775 patients were pooled. Pooled hazard ratios (HRs) and odds ratios (ORs) were calculated to assess the prognostic value of LINC00152. The results revealed that tumour patients with high LINC00152 expression were more likely to have lymph node metastasis (OR = 2.94, 95% CI 1.97–4.40, P < 0.001) and unfavourable tumour–node–metastasis stage (grade III/IV vs. I/II: OR = 3.07, 95% CI 1.69–5.59, P < 0.001). In addition, high LINC00152 expression levels were significantly associated with poor overall survival (pooled HR = 1.99, 95% CI 1.54–2.56, P < 0.001). The results suggest that high LINC00152 expression may serve as a predictive biomarker for the poor prognosis of various cancers in the Chinese population.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21838

Publication Alerts

Post-Publication Promotion

Publication Discount

Meta-Analysis:

Prognostic role of long non-coding RNA LINC00152 in Chinese cancer patients: a meta-analysis

Abstract